Tuesday, August 9, 2022
Home Tags Disease and conditions

Disease and conditions Related News

Health Europa Quarterly

Health Europa Quarterly Issue 22

Welcome to Health Europa Quarterly Issue 22, which features fascinating expert insights in the fields of public health, Alzheimer's disease, antimicrobial resistance, women’s health, nutrition,...
Low-intensity Vibration Therapy: Combatting an osteoporosis epidemic

Low-intensity Vibration Therapy: Combatting an osteoporosis epidemic

MyBones outlines the challenges to global bone health revealed by SCOPE 2021, and how Low-intensity Vibration therapy offers an innovative way to prevent and...

Amarin: Rethinking Cardiovascular Risk in Europe

At Amarin, we are committed to improving the lives of high-risk cardiovascular patients across Europe by establishing innovative treatments for cardiovascular disease (CVD). This advertorial...
Water testing

Mitigating contamination threats with microbial analysis and water testing

Nova Biologicals, a leading microbiological testing service, outlines how microscopic contaminants can be mitigated and contained through microbial analysis methods such as water testing. Microscopic...
Transforming diagnostic testing for biomarkers with Egoo.health platform

Transforming diagnostic testing for biomarkers with Egoo.health platform

Egoo.Health Platform is transforming testing for biomarkers with their diagnostics device, which delivers everyone from ordinary people to healthcare professionals, the opportunity to monitor...

Marodyne LiV: enhancing bone health with effective osteoporosis treatment

Introducing Marodyne LiV, an innovative osteoporosis treatment that expertly inhibits and mitigates the condition, significantly boosting bone health. Low-intensity vibration (LiV) is a clinically proven...
Big Boost for NervGen’s Phase II Clinical Trials

Big Boost for NervGen’s Phase II Clinical Trials

In a groundbreaking development for paralysed people, the revolutionary NVG-291 treatment for spinal cord injury is set to undergo Phase II clinical trials in...
Amarin: Changing the landscape of residual cardiovascular disease risk

Amarin: Changing the landscape of residual cardiovascular disease risk

World-leading pioneers of the pharmaceutical industry, Amarin Corporation, comprehensively explore the ever-evolving landscape of cardiovascular disease, analysing the current challenges facing mitigating the impacts...
An innovative device for multi-organ failure support

An innovative device for multi-organ failure support

The ADVOS integrated 4-in-1 multi-organ support solution could dramatically improve survival rates of critically ill organ failure patients, including those with COVID-19. Multi-organ failure (MOF)...
MonitAir: Empowering patients to monitor their symptoms of COPD

MonitAir: Empowering patients to monitor their symptoms of COPD

MonitAir is a cutting-edge eHealth product that enables patients to monitor their symptoms of COPD accurately, providing them with unprecedented insights into their condition...
long-COVID

Understanding the impact of long COVID to improve future treatment

A study into long COVID has highlighted the need for greater research, diagnostic procedures, and pandemic preparedness moving forward. For the foreseeable future, the coronavirus...
taste-and-smell-loss

Research highlights lack of support for taste and smell loss patients

People who have lost their sense of smell are not getting the support they need from the healthcare system, new research has suggested. A study...
Revolutionising the study of the cellular origins of disease

Revolutionising the study of the cellular origins of disease

A breakthrough in microscopy and endoscopy is set to revolutionise how we study the cellular origin of diseases – advancing the field of precision...
Advancing understanding of TB and respiratory infections with lung-on-chip

Advancing understanding of TB and respiratory infections with lung-on-chip

An innovative ‘lung-on-chip’ is providing new insights into the body’s response to early tuberculosis infection and could provide a model for future research into...
Cystic fibrosis: searching for a cure

Cystic fibrosis: searching for a cure

The Cystic Fibrosis Foundation aims to deliver treatment, care and – eventually – a cure for CF. Cystic fibrosis (CF), which affects more than 70,000...
Molecular cause explains a genetic form of microcephaly

Molecular cause explains a genetic form of microcephaly

Scientists have helped to explain a genetic form of microcephaly by uncovering a molecular cause for the rare disease. Microcephaly is a condition where babies'...
Bridging the gap in heart failure awareness

Bridging the gap in heart failure awareness

While heart failure affects 64 million people worldwide, a new Global survey shows that heart failure is a ‘blind spot’ for the public and...
Experimental cancer drug is potential treatment for rare Rett syndrome

Experimental cancer drug is potential treatment for rare Rett syndrome

Scientists have investigated the use of an experimental cancer drug for the treatment of the rare Rett syndrome, finding that it extended life in...
Better control of blood sugar for diabetics with two-in-one injection

Better control of blood sugar for diabetics with two-in-one injection

An experimental two-in-one insulin injection has been created to help diabetics gain better control of their blood sugar. The injection, developed by researchers at Stanford...
Discover how AI can help with early detection of glaucoma

Discover how AI can help with early detection of glaucoma

A new test combined with Artificial Intelligence is able to detect glaucoma progression up to 18 months earlier than current tests. Glaucoma, the leading global...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest